Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Cardiology/Vascular Diseases
Atrial Fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
A Multicenter, Randomized, Double-Blind, Assessor-Blind, Non-Inferiority Study Comparing the Efficacy and Safety of Once- Weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) with Oral Adjusted-Dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients with Atrial Fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of Apixaban In Preventing Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Atrial Fibrillation study for the evaluation and safety of a medication for people with atrial fibrillation.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
A phase II, study to assess the safety and effect on ventricular rate of multiple oral doses of study drug in adult subjects with atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Clinical Research Study for Adult Subjects with Nonvalvular Atrial Fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Cardiology & Vascular Diseases: Volunteers Needed for Atrial Fibrillation Study
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Atrial Fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Has your doctor told you that you have Atrial Fibrillation (AF)?
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Atrial Fibrilation- Multidose Safety and Tolerability Study of (Arikaceā¢) for Inhalation In Cystic Fibrosis Patients
Atrial Fibrillation- Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)
Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-Dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation (BOREALIS-AF)
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
ATRIAL FIBRILLATION: Have you been diagnosed with Atrial Fibrillation in the last year?
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Has your doctor told you that you have Atrial Fibrillation (AF)?
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Atrial Fibrillation - Houston, TX
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Atrial Fibillation patients undergoing cardioversion wanted for research study
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
The Warfarin-SMART Study